Eisai
4523.T
#2183
Rank
S$10.97 B
Marketcap
S$38.90
Share price
0.11%
Change (1 day)
-0.84%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Eisai (4523.T) - Total debt

Total debt on the balance sheet as of September 2025 : S$2.07 Billion

According to Eisai's latest financial reports the company's total debt is S$2.07 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Eisai - Total debt on balance sheet (from 2009 to 2025)

Total debt by year

Year Total debt Change
2025-03-31S$1.68 B18.41%
2024-03-31S$1.41 B12.83%
2023-03-31S$1.25 B19.15%
2022-03-31S$1.05 B-3.32%
2021-03-31S$1.09 B-8.21%
2020-03-31S$1.18 B-29.82%
2019-03-31S$1.69 B-20.64%
2018-03-31S$2.13 B-20.3%
2017-03-31S$2.67 B9.79%
2016-03-31S$2.44 B-9.65%
2015-03-31S$2.70 B-10.39%
2014-03-31S$3.01 B-27.08%
2013-03-31S$4.13 B-21.06%
2012-03-31S$5.23 B-8.81%
2011-03-31S$5.74 B-5.89%
2010-03-31S$6.10 B-6.02%
2009-03-31S$6.49 B16.37%
2008-03-31S$5.57 B183406.83%
2007-03-31S$3.04 M-46.71%
2006-03-31S$5.7 M-55.59%
2005-03-31S$12.84 M317.65%
2004-03-31S$3.07 M486.25%
2003-03-31S$0.52 M-99.42%
2002-03-31S$90.53 M-20.22%
2001-03-31S$0.11 B-61.64%
2000-03-31S$0.29 B